AI and Biotechnology: Navigating Opportunities and Risks in the Bioeconomy

Last month’s Bioprocessing Venture, Innovation, and Partnering Conference brought together thought leaders from across the bioeconomy to discuss the rapidly evolving landscape of artificial intelligence (AI) in biotechnology.

Panel moderator Lori Ellis, BioSpace, began by defining the space. She asked Sarah Glaven, principle assistant director, biotechnology and biomanufacturing, White House Office of Science and Technology Policy, to help clarify the White House’s recent Bioeconomy Executive Order, which aims to stimulate economic growth by focusing on protection, security, and ensuring AI’s benefits outweigh the costs to the American people. While the Bioprocessing Summit focuses on the pharmaceutical industry and biomedical space, “the bioeconomy executive order, as we call it,” Glaven said, “touches on everything from health to...

Today's Sponsors

Today's Sponsor